Tag antiangiogenic [42 articles] Export Sort

Recent papers classified by the tag antiangiogenic.

Hide details

	Antiangiogenic (metronomic) chemotherapy for brain tumors: current and future perspectives. [My Copy] Expert opinion on investigational drugs, Vol. 18, No. 7. (July 2009), pp. 973-983. by D. P. Samuel, P. Y. Wen, M. W. Kieran posted to antiangiogenic brain cancer chemotherapy metronomic-schedule by xtizon on 2009-06-30 07:55:51 as
	Inhibition of tyrosine kinase receptors by SU6668 promotes abnormal stromal development at the periphery of carcinomas [My Copy] British Journal of Cancer, Vol. aop, No. current. (21 April 2009) by P. Farace, M. Gali￨, F. Merigo, et al.A. Daducci, L. Calderan, E. Nicolato, A. Degrassi, E. Pesenti, A. Sbarbati, P. Marzola posted to antiangiogenic biology dce-mri small-animal tumor by xtizon on 2009-05-14 21:18:05 as
	Differential CD146 Expression on Circulating Versus Tissue Endothelial Cells in Rectal Cancer Patients: Implications for Circulating Endothelial and Progenitor Cells As Biomarkers for Antiangiogenic Therapy [My Copy] J Clin Oncol, Vol. 24, No. 9. (20 March 2006), pp. 1449-1453. by Dan G. Duda, Kenneth S. Cohen, Emmanuelle di Tomaso, et al.Patrick Au, Rachael J. Klein, David T. Scadden, Christopher G. Willett, Rakesh K. Jain posted to antiangiogenic biomarker syn_ai_042009 by xtizon on 2009-04-15 09:54:22 as
	Predicting benefit from anti-angiogenic agents in malignancy [My Copy] Nature Reviews Cancer, Vol. 6, No. 8. (13 July 2006), pp. 626-635. by Adrian M. Jubb, Adam J. Oates, Scott Holden, Hartmut Koeppen posted to antiangiogenic biomarker cancer review syn_ai_042009 by xtizon on 2009-04-15 09:33:37 as along with 1 person guhjy
	Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. [My Copy] Cancer cell, Vol. 15, No. 3. (3 March 2009), pp. 232-239. by John M. Ebos, Christina R. Lee, William Cruz-Munoz, Georg A. Bjarnason, James G. Christensen, Robert S. Kerbel posted to antiangiogenic cancer metastasis by xtizon on 2009-04-14 09:47:35 as along with 3 people zhuyao justincisar catcremona
	Vascular permeability during antiangiogenesis treatment: MR imaging assay results as biomarker for subsequent tumor growth in rats. [My Copy] Radiology, Vol. 247, No. 2. (May 2008), pp. 391-399. by H. J. Raatschen, G. H. Simon, Y. Fu, et al.B. Sennino, D. M. Shames, M. F. Wendland, D. M. McDonald, R. C. Brasch posted to angiogenesis antiangiogenic mri permeability predictive animal-models by xtizon on 2009-04-08 21:50:54 as
	Modes of resistance to anti-angiogenic therapy. [My Copy] Nature reviews. Cancer, Vol. 8, No. 8. (August 2008), pp. 592-603. by Gabriele Bergers, Douglas Hanahan posted to antiangiogenic resistance review by xtizon on 2009-04-07 21:56:38 as along with 1 person zhuyao
	VEGF-targeted therapy: mechanisms of anti-tumour activity [My Copy] Nature Reviews Cancer, Vol. 8, No. 8. (03 July 2008), pp. 579-591. by Lee M. Ellis, Daniel J. Hicklin posted to antiangiogenic biology review vegf by xtizon on 2009-04-07 21:55:44 as along with 2 people DianaC reyez
	Lessons from phase III clinical trials on anti-VEGF therapy for cancer. [My Copy] Nature clinical practice. Oncology, Vol. 3, No. 1. (January 2006), pp. 24-40. by R. K. Jain, D. G. Duda, J. W. Clark, J. S. Loeffler posted to antiangiogenic cancer clinical-trial review vegf by xtizon on 2009-04-02 22:08:14 as
	Sunitinib: From Rational Design to Clinical Efficacy [My Copy] J Clin Oncol, Vol. 25, No. 7. (1 March 2007), pp. 884-896. by Laura Q. Chow, Gail S. Eckhardt posted to antiangiogenic review sunitinib by xtizon on 2009-03-30 12:50:30 as
	Silencing or Fueling Metastasis with VEGF Inhibitors: Antiangiogenesis Revisited [My Copy] Vol. 15, No. 3. (3 March 2009), pp. 167-170. by Sonja Loges, Massimiliano Mazzone, Philipp Hohensinner, Peter Carmeliet posted to antiangiogenic metastasis resistance review syn_ai_042009 by xtizon on 2009-03-27 16:57:30 as
	mTOR Inhibitor RAD001 (Everolimus) Has Antiangiogenic/Vascular Properties Distinct from a VEGFR Tyrosine Kinase Inhibitor [My Copy] Clin Cancer Res, Vol. 15, No. 5. (1 March 2009), pp. 1612-1622. by Heidi A. Lane, Jeanette M. Wood, Paul M. Mcsheehy, et al.Peter R. Allegrini, Anne Boulay, Joseph Brueggen, Amanda Littlewood-Evans, Sauveur-Michel Maira, Georg Martiny-Baron, Christian R. Schnell, Patrizia Sini, Terence O'Reilly posted to antiangiogenic cancer mtor by xtizon on 2009-03-20 14:56:28 as
	Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies. [My Copy] Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, Vol. 11, No. 6. (December 2008), pp. 219-230. by F. Shojaei, N. Ferrara posted to antiangiogenic cancer escape microenvironment resistance by xtizon on 2009-03-19 07:16:17 as
	Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. [My Copy] Nature medicine, Vol. 10, No. 2. (February 2004), pp. 145-147. by C. G. Willett, Y. Boucher, E. di Tomaso, et al.D. G. Duda, L. L. Munn, R. T. Tong, D. C. Chung, D. V. Sahani, S. P. Kalva, S. V. Kozin, M. Mino, K. S. Cohen, D. T. Scadden, A. C. Hartford, A. J. Fischman, J. W. Clark, D. P. Ryan, A. X. Zhu, L. S. Blaszkowsky, H. X. Chen, P. C. Shellito, G. Y. Lauwers, R. K. Jain posted to antiangiogenic bevacizumab cancer by xtizon on 2009-03-04 17:11:53 as along with 1 person djmonstermo
	Anti-angiogenic therapies in cancer: achievements and open questions. [My Copy] Bulletin du cancer, Vol. 94, No. 9. (1 September 2007), pp. 753-762. by C. Ruegg, N. Mutter posted to antiangiogenic cancer review toget by xtizon on 2009-03-03 09:50:10 as
	Lessons from multidisciplinary translational trials on anti-angiogenic therapy of cancer [My Copy] Nature Reviews Cancer, Vol. 8, No. 4., pp. 309-316. by Rakesh K. Jain posted to antiangiogenic cancer review toget by xtizon on 2009-03-03 09:47:42 as
	Clinical biomarkers of angiogenesis inhibition [My Copy] Cancer and Metastasis Reviews, Vol. 27, No. 3. (2008), pp. 415-434. by Aaron Brown, Deborah Citrin, Kevin Camphausen posted to antiangiogenic biomarker review by xtizon on 2009-02-19 08:01:37 as
	Clinical biomarkers of kinase activity: examples from EGFR inhibition trials [My Copy] Cancer and Metastasis Reviews, Vol. 27, No. 3. (2008), pp. 387-402. by Mechthild Krause, Michael Baumann posted to antiangiogenic biomarker kinase by xtizon on 2009-02-19 08:01:09 as along with 1 person guhjy
	Redefining the Target: Chemotherapeutics as Antiangiogenics [My Copy] J Clin Oncol, Vol. 19, No. 4. (15 February 2001), pp. 1195-1206. by Kathy D. Miller, Christopher J. Sweeney, George W. Sledge posted to antiangiogenic chemotherapy review by xtizon on 2009-02-06 09:00:52 as
	Anti-tumor activity and tumor vessel normalization by the vascular endothelial growth factor receptor tyrosine kinase inhibitor KRN951 in a rat peritoneal disseminated tumor model [My Copy] Cancer Science, Vol. 99, No. 3. (March 2008), pp. 623-630. by Taguchi, Eri, Nakamura, et al. Kazuhide, Miura, Toru, Shibuya, Masabumi, Isoe, Toshiyuki posted to antiangiogenic mri response vascular-normalization animal-models by xtizon on 2009-01-19 08:53:49 as
	Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2. [My Copy] Cancer cell, Vol. 6, No. 5. (November 2004), pp. 507-516. by J. Oliner, H. Min, J. Leal, et al.D. Yu, S. Rao, E. You, X. Tang, H. Kim, S. Meyer, S. J. Han, N. Hawkins, R. Rosenfeld, E. Davy, K. Graham, F. Jacobsen, S. Stevenson, J. Ho, Q. Chen, T. Hartmann, M. Michaels, M. Kelley, L. Li, K. Sitney, F. Martin, J. R. Sun, N. Zhang, J. Lu, J. Estrada, R. Kumar, A. Coxon, S. Kaufman, J. Pretorius, S. Scully, R. Cattley, M. Payton, S. Coats, L. Nguyen, B. Desilva, A. Ndifor, I. Hayward, R. Radinsky, T. Boone, R. Kendall posted to antiangiogenic by xtizon on 2009-01-09 15:10:22 as
	AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. [My Copy] Cancer cell, Vol. 11, No. 1. (January 2007), pp. 83-95. by T. T. Batchelor, A. G. Sorensen, E. di Tomaso, et al.W. T. Zhang, D. G. Duda, K. S. Cohen, K. R. Kozak, D. P. Cahill, P. J. Chen, M. Zhu, M. Ancukiewicz, M. M. Mrugala, S. Plotkin, J. Drappatz, D. N. Louis, P. Ivy, D. T. Scadden, T. Benner, J. S. Loeffler, P. Y. Wen, R. K. Jain posted to antiangiogenic glioma vascular-normalization by xtizon on 2009-01-09 13:48:30 as along with 1 person ajaymalik
	Antiangiogenic agents for the treatment of glioblastoma [My Copy] Expert Opinion on Investigational Drugs, Vol. 16, No. 12. (December 2007), pp. 1895-1908. by Gerstner, R. Elizabeth, Duda, et al.G. Dan, Tomaso, Emmanuelle Di, Sorensen, Greg, Jain, K. Rakesh, Batchelor, T. Tracy posted to antiangiogenic glioma review by xtizon on 2009-01-09 13:45:59 as
	Measuring tumour vascular response to antivascular and antiangiogenic drugs [My Copy] Br J Radiol, Vol. 76, No. suppl_1. (1 December 2003), pp. S23-35. by G. M. Tozer posted to antiangiogenic antivascular response tumor vasculature by xtizon on 2009-01-07 10:45:25 as along with 1 person standara
	PTK787/ZK222584, a tyrosine kinase inhibitor of vascular endothelial growth factor receptor, reduces uptake of the contrast agent GdDOTA by murine orthotopic B16/BL6 melanoma tumours and inhibits their growth <I>in vivo</I> [My Copy] NMR in Biomedicine, Vol. 18, No. 5. (2005), pp. 308-321. by Markus Rudin, Paul M. J. Mcsheehy, Peter R. Allegrini, et al.Martin Rausch, Diana Baumann, Mike Becquet, Karin Brecht, Josef Brueggen, Stephane Ferretti, Fabienne Schaeffer, Christian Schnell, Jeanette Wood posted to antiangiogenic dce-mri by xtizon on 2008-11-12 22:34:16 as
	Magnetic resonance imaging-based detection of glial brain tumors in mice after antiangiogenic treatment. [My Copy] International journal of cancer. Journal international du cancer, Vol. 122, No. 9. (1 May 2008), pp. 1981-1986. by A. Claes, G. Gambarota, B. Hamans, et al.O. van Tellingen, P. Wesseling, C. Maass, A. Heerschap, W. Leenders posted to antiangiogenic diagnosis gd-dtpa glioma uspio by xtizon on 2008-11-07 17:18:03 as
	Anticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumors. [My Copy] Cancer research, Vol. 67, No. 8. (15 April 2007), pp. 3560-3564. by C. Folkins, S. Man, P. Xu, Y. Shaked, D. J. Hicklin, R. S. Kerbel posted to antiangiogenic combination cytotoxic glioma by xtizon on 2008-11-07 17:12:53 as
	Antiangiogenic therapy in malignant glioma: promise and challenge. [My Copy] Current pharmaceutical design, Vol. 13, No. 35. (2007), pp. 3545-3558. by S. Sathornsumetee, J. N. Rich posted to antiangiogenic brain cancer glioma review treatment by xtizon on 2008-11-07 17:03:01 as
	Antiangiogenesis treatment for glioblastoma multiforme: challenges and opportunities. [My Copy] Journal of the National Comprehensive Cancer Network : JNCCN, Vol. 6, No. 5. (May 2008), pp. 515-522. by E. T. Wong, S. Brem posted to antiangiogenic brain cancer review treatment by xtizon on 2008-11-07 17:00:50 as
	Drug Insight: vascular disrupting agents and angiogenesis[mdash]novel approaches for drug delivery [My Copy] Nat Clin Prac Oncol, Vol. 3, No. 12. (December 2006), pp. 682-692. by Matthew M. Cooney, Willem van Heeckeren, Shyam Bhakta, Jose Ortiz, Scot C. Remick posted to antiangiogenic cancer review vta by xtizon on 2008-10-19 20:37:14 as
	Prediction of antiangiogenic treatment efficacy by iron oxide enhanced parametric magnetic resonance imaging. [My Copy] Investigative radiology, Vol. 42, No. 12. (December 2007), pp. 791-796. by T. Persigehl, L. Matuszewski, T. Kessler, et al.A. Wall, N. Meier, W. Ebert, W. E. Berdel, W. Heindel, R. Mesters, C. Bremer posted to antiangiogenic blood-volume uspio by xtizon on 2008-09-16 08:15:42 as along with 1 person standara
	Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity [My Copy] Mol Cancer Ther, Vol. 6, No. 7. (1 July 2007), pp. 2012-2021. by Rakesh Kumar, Victoria B. Knick, Sharon K. Rudolph, et al.Jennifer H. Johnson, Renae M. Crosby, Ming-Chih Crouthamel, Teresa M. Hopper, Charles G. Miller, Laura E. Harrington, James A. Onori, Robert J. Mullin, Tona M. Gilmer, Anne T. Truesdale, Andrea H. Epperly, Amogh Boloor, Jeffrey A. Stafford, Deirdre K. Luttrell, Mui Cheung posted to antiangiogenic cancer pk-pd therapy by xtizon on 2008-08-22 16:43:04 as
	Evaluation of [18F]gefitinib as a molecular imaging probe for the assessment of the epidermal growth factor receptor status in malignant tumors [My Copy] European Journal of Nuclear Medicine and Molecular Imaging, Vol. 35, No. 6. (14 June 2008), pp. 1089-1099. by Helen Su, Yann Seimbille, Gregory Ferl, et al.Claudia Bodenstein, Barbara Fueger, Kevin Kim, Yu-Tien Hsu, Steven Dubinett, Michael Phelps, Johannes Czernin, Wolfgang Weber posted to antiangiogenic molecular-imaging pet pharmaco-dynamic by xtizon to the group Positron-Emission-Tomography on 2008-05-18 17:03:58 as
	Antiangiogenic gene therapy of cancer: recent developments [My Copy] Journal of Translational Medicine, Vol. 2, No. 1. (2004) by Anita Tandle, Dan Blazer, Steven Libutti posted to antiangiogenic cancer gene review by xtizon on 2007-09-15 16:04:04 as
	Effects of AZD2171 and vandetanib (ZD6474, Zactima) on haemodynamic variables in an SW620 human colon tumour model: an investigation using dynamic contrast-enhanced MRI and the rapid clearance blood pool contrast agent, P792 (gadomelitol) [My Copy] NMR in Biomedicine, Vol. 9999, No. 9999. (2007), n/a. by D. P. Bradley, J. L. Tessier, D. Checkley, et al.H. Kuribayashi, J. C. Waterton, J. Kendrew, S. R. Wedge posted to antiangiogenic blood-pool-ca colon dce-mri mri p792 by xtizon on 2007-08-21 12:53:54 as
	Effect of vascular normalization by antiangiogenic therapy on interstitial hypertension, peritumor edema, and lymphatic metastasis: insights from a mathematical model. [My Copy] Cancer Res, Vol. 67, No. 6. (15 March 2007), pp. 2729-2735. by R. K. Jain, R. T. Tong, L. L. Munn posted to antiangiogenic by Kyaita on 2007-05-26 04:30:30 as along with 2 people nicholasflann xtizon
	Anti-angiogenic therapy: rationale, challenges and clinical studies. [My Copy] Angiogenesis, Vol. 5, No. 4. (2002), pp. 237-256. by R. Longo, R. Sarmiento, M. Fanelli, B. Capaccetti, D. Gattuso, G. Gasparini posted to antiangiogenic cancer by xtizon on 2007-03-07 14:00:36 as
	Combination of antiangiogenic therapy with other anticancer therapies: results, challenges, and open questions. [My Copy] J Clin Oncol, Vol. 23, No. 6. (20 February 2005), pp. 1295-1311. by G. Gasparini, R. Longo, M. Fanelli, B. A. Teicher posted to antiangiogenic cancer combination cytotoxic syn_ai_042009 by xtizon on 2007-03-07 10:28:41 as
	Metronomic scheduling: the future of chemotherapy? [My Copy] Lancet Oncol, Vol. 2, No. 12. (December 2001), pp. 733-740. by G. Gasparini posted to antiangiogenic cancer cytotoxic by xtizon on 2007-03-07 10:20:51 as
	DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents [My Copy] British Journal of Cancer, Vol. 96, No. 2. (09 January 2007), pp. 189-195. by J. P. B. O'Connor, A. Jackson, G. J. M. Parker, G. C. Jayson posted to antiangiogenic antivascular dce-mri review syn_ai_042009 by xtizon on 2007-02-16 08:27:59 as along with 3 people standara microserf anitabanerji
	Antiangiogenic cancer gene therapy by adeno-associated virus 2-mediated stable expression of the soluble FMS-like tyrosine kinase-1 receptor. [My Copy] Cancer Gene Ther, Vol. 12, No. 1. (January 2005), pp. 26-34. by G. Mahendra, S. Kumar, T. Isayeva, et al.P. J. Mahasreshti, D. T. Curiel, C. R. Stockardt, W. E. Grizzle, V. Alapati, R. Singh, G. P. Siegal, S. Meleth, S. Ponnazhagan posted to aav2 antiangiogenic fms-like gene kinase-1 receptor soluble therapy tyrosine by tk007 on 2006-02-15 14:24:14 as
	Adeno-associated virus 2-mediated antiangiogenic cancer gene therapy: long-term efficacy of a vector encoding angiostatin and endostatin over vectors encoding a single factor. [My Copy] Cancer Res, Vol. 64, No. 5. (1 March 2004), pp. 1781-1787. by S. Ponnazhagan, G. Mahendra, S. Kumar, et al.D. R. Shaw, C. R. Stockard, W. E. Grizzle, S. Meleth posted to aav2 angiostatin antiangiogenic endostatin gene therapy by tk007 on 2006-02-15 14:18:30 as

Note: You may cite this page as: http://www.citeulike.org/tag/antiangiogenic

Sort by:
Order:	Default Ascending Descending
Empty fields:	Default First Last

cancer	19
review	19
biomarker	5
glioma	5
syn_ai_042009	5
dce-mri	4
brain	3
cytotoxic	3
gene	3
mri	3
resistance	3
therapy	3
uspio	3
aav2	2
animal-models	2
antivascular	2
biology	2
blood-volume	2
chemotherapy	2
combination	2
metastasis	2
molecular-imaging	2
pet	2
pharmaco-dynamic	2
response	2
toget	2
treatment	2
tumor	2
vascular-normalization	2
vegf	2
angiogenesis	1
angiostatin	1
bevacizumab	1
blood-pool-ca	1
clinical-trial	1
colon	1
diagnosis	1
endostatin	1
escape	1
fms-like	1
gd-dtpa	1
kinase	1
kinase-1	1
metronomic-schedule	1
microenvironment	1
mtor	1
p792	1
permeability	1
pk-pd	1
predictive	1
receptor	1
small-animal	1
soluble	1
sunitinib	1
tyrosine	1
vasculature	1
vta	1

Tag antiangiogenic [42 articles] Export Sort

Related Tags